Cassandra D Kinch (Cassandra Kinch)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Cardiovascular Risk Factors

Top Venues

Rheumatology and therapy

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Grace C Wright, Eduardo Mysler, Kenneth Kwok, Mary Jane Cadatal, Rebecca Germino, Arne Yndestad, Cassandra D Kinch, Alexis Ogdie
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials. Rheumatology and therapy (2024)
Xiaomei Leng, Wei Lin, Shixue Liu, Keith Kanik, Cunshan Wang, Weiguo Wan, Zhenyu Jiang, Yi Liu, Shengyun Liu, Zhuoli Zhang, Zhiyi Zhang, Jian Xu, Wenfeng Tan, Jiankang Hu, Jingyang Li, Ju Liu, Levent M Gunay, Oluwaseyi Dina, Cassandra D Kinch, Xiaofeng Zeng
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. RMD open 9 (1) (2023)
Gerd R Burmester, Laura C Coates, Stanley B Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-Shine Chen, Kenneth Kwok, Lara Fallon, Cassandra D Kinch
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis. Rheumatology and therapy (2023)
Gerd R Burmester, Laura C Coates, Stanley B Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-Shine Chen, Kenneth Kwok, Lara Fallon, Cassandra D Kinch
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis. Rheumatology and therapy (2023)
Xiaomei Leng, Wei Lin, Shixue Liu, Keith Kanik, Cunshan Wang, Weiguo Wan, Zhenyu Jiang, Yi Liu, Shengyun Liu, Zhuoli Zhang, Zhiyi Zhang, Jian Xu, Wenfeng Tan, Jiankang Hu, Jingyang Li, Ju Liu, Levent M Gunay, Oluwaseyi Dina, Cassandra D Kinch, Xiaofeng Zeng
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. RMD open 9 (1) (2023)
Xiaomei Leng, Wei Lin, Shixue Liu, Keith Kanik, Cunshan Wang, Weiguo Wan, Zhenyu Jiang, Yi Liu, Shengyun Liu, Zhuoli Zhang, Zhiyi Zhang, Jian Xu, Wenfeng Tan, Jiankang Hu, Jingyang Li, Ju Liu, Levent M Gunay, Oluwaseyi Dina, Cassandra D Kinch, Xiaofeng Zeng
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. RMD open 9 (1) (2023)
Louis Bessette, Eduardo Mysler, Cassandra D Kinch, Kenneth Kwok, Tatjana Lukic, Phu Vinh On, Ronald F Van Vollenhoven
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials. The Journal of rheumatology 49 (6) (2022)
Louis Bessette, Cassandra D Kinch
Drs. Bessette and Kinch reply. The Journal of rheumatology (2022)